Comparison of Aspirin and Rivaroxaban Plus Aspirin in the Management of Stable Coronary Artery Disease or Peripheral Artery Disease: A Systematic Review of Randomized Controlled Trials-Reference-Cited by-同舟云学术

Comparison of Aspirin and Rivaroxaban Plus Aspirin in the Management of Stable Coronary Artery Disease or Peripheral Artery Disease: A Systematic Review of Randomized Controlled Trials

Published:2022-09 Issue: Volume:Volume 15 Page:7201-7208
ISSN:1178-7074
Container-title:International Journal of General Medicine
language:en
Short-container-title:IJGM

Author:

Debasu Zenaw,Kedir Hanan Muzeyin^ORCID,Tadesse Tamrat Assefa^ORCID

Publisher

Informa UK Limited

Subject

General Medicine

Reference31 articles.

1. Mechanisms of Acute Coronary Syndromes and Their Implications for Therapy

2. International Prevalence, Recognition, and Treatment of Cardiovascular Risk Factors in Outpatients With Atherothrombosis

3. Progress and challenges in translating the biology of atherosclerosis

4. Rivaroxaban: A New Treatment Paradigm in the Setting of Vascular Protection?

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of drugs in residual cardiovascular risk: A systematic review of the literature;International Journal of Cardiology Cardiovascular Risk and Prevention;2024-09

2. Association between endothelin-1, nitric oxide, and Gensini score in chronic coronary syndrome;BMC Cardiovascular Disorders;2023-12-08

3. Development and application of HPTLC method for estimation of Rivaroxaban and Aspirin in bulk drug and in-house tablet form;Journal of Chemical Metrology;2022-12-31

4. Efficacy and safety of acupuncture combined with Xuefu Zhuyu Decoction on major adverse cardiovascular events after percutaneous coronary intervention: A protocol for systematic review and meta-analysis;Medicine;2022-11-18